Benefits and perks at Delfi Diagnostics Inc.
Delfi Diagnostics Inc. hasn't added any benefits
If you work at Delfi Diagnostics Inc., you can claim your profile and add your tech stack.
Claim Delfi Diagnostics Inc.Discover the employees benefits and perks available to Delfi Diagnostics Inc. employees.
If you work at Delfi Diagnostics Inc., you can claim your profile and add your tech stack.
Claim Delfi Diagnostics Inc.51-200 employees
2018
Susan Tousi
Try our AI resume builder, interview practice, and cover letter generator for free. Then, unlock unlimited use for just $9/month.
View all toolsExplore the variety of open remote roles at Delfi Diagnostics Inc., offering flexible work options across multiple disciplines and skill levels.
Find your next opportunity by exploring profiles of companies that are similar to Delfi Diagnostics Inc.. Compare culture, benefits, and job openings on Himalayas.
Sign up now and join over 85,000 remote workers who receive personalized job alerts, curated job matches, and more for free!
Sign up now and join over 85,000 remote workers who receive personalized job alerts, curated job matches, and more for free!
Employee count: 51-200
Salary: 330k-387k USD
Employee count: 51-200
Salary: 175k-210k USD
Employee count: 51-200
Employee count: 51-200
Salary: 245k-280k USD
Employee count: 51-200
Employee count: 51-200
Salary: 120k-155k USD
Find your next opportunity by exploring profiles of companies that are similar to Delfi Diagnostics Inc.. Compare culture, benefits, and job openings on Himalayas.
Freenome is a biotechnology company developing blood tests for early cancer detection using a multiomics platform that combines molecular biology, computational biology, and machine learning. Their initial focus is on colorectal and lung cancer.
Veracyte, Inc. is a global diagnostics company dedicated to revolutionizing cancer care through innovative genomic testing solutions.
GRAIL is a healthcare company focused on detecting cancer early, when it can be cured, through the development and commercialization of pioneering multi-cancer early detection blood tests like Galleri®.
CancerIQ is a company focused on enhancing cancer prevention and early detection through technology, providing health systems with tools to leverage genetic information in patient care.
SAGA Diagnostics focuses on ultrasensitive cancer diagnostics through advanced liquid biopsy technologies, enabling personalized treatment and monitoring.
Adaptive Biotechnologies is a commercial-stage biotechnology company that harnesses the adaptive immune system's biology to transform disease diagnosis and treatment, offering an immune-sequencing platform for research and clinical diagnostics.